GangnamSeverance Hospital
Seoul, South Korea
NCT Number: NCT05917834
This study aims to assess nipple areolar complex sensation after nipple sparing mastectomy and compare the results according to different incisional approaches; specifically, inframammary fold (IMF) versus peri-areolar/radial. One-hundred-and-five post NSM patients from Oct 2019 to Nov 2021 have been recruited prospectively and evaluated for NAC sensory. A total of 97 patients (IMF 65 and peri-areolar/radial 32) were included in the analyses for comparison during follow up from 24 to 48 months after surgery. It was hypothesized that patients with IMF would have better outcomes for NAC senroy.
Looking for future studies?
Notify Me18 year and older
Female
Observational
Seoul, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Nipple sparing mastectomy was performed using Radial/Peri-areolar incision or imframammary incision
Time frame: 2-4 years after surgery
Difference in NAC sensory loss between the patients with two different incisions.
Gangnam Severance Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06384417
Breast Cancer, Breast Diseases
Hershey, Pennsylvania, United States
View Trial DetailsNCT04902872
Adnexal Diseases, Appendiceal Neoplasms
New Haven, Connecticut, United States
View Trial DetailsNCT06865534
Breast Cancer, Breast Diseases
Marburg, Germany
View Trial DetailsNCT05889728
Breast Cancer, Breast Diseases
Sydney, New South Wales, Australia
View Trial Details